Yi Nan Wang
Direktor/Vorstandsmitglied bei Cardiolink Science (Shenzhen) Med Tech Development Co., Ltd.
Profil
Alan Wang is a Principal at LYFE Capital.
Prior to joining LYFE Capital, he worked as a marketing manager at Bristol-Myer Squibb (NYSE: BMS).
Alan has served as an important team member who focuses on the medical device/ diagnostic areas.
He was deeply involved with one of LYFE’s landmark deals Kangji (HK: 09997) and has helped driving it into a global platform.
He obtained his MBA from Cheung Kong Graduate School of Business and received his master’s in physiology from East China Normal University.
He was initially trained in biotechnology at Shandong University.
Aktive Positionen von Yi Nan Wang
| Unternehmen | Position | Beginn |
|---|---|---|
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd.
 Zhouling Private Equity Fund Management (Shanghai) Co., Ltd. Investment ManagersFinance Zhouling Private Equity Fund Management (Shanghai) Co Ltd (LYFE Capital) is a private equity/venture capital firm founded in 2015 by James Zhao. The firm is headquartered in Shanghai, China. | Corporate Officer/Principal | - |
Hangzhou Kangji Medical Instrument Co., Ltd.
 Hangzhou Kangji Medical Instrument Co., Ltd. Medical DistributorsDistribution Services Hangzhou Kangji Medical Instrument Co., Ltd. manufactures and distributes medical equipment and related accessories. Its business includes reusable and disposable instruments for laparoscopy, gynecology, urology, gastroenterology, and ENT specialties. The company was founded on August 24, 2004 and is headquartered in Hangzhou, China. | Direktor/Vorstandsmitglied | - |
Cardiolink Science (Shenzhen) Med Tech Development Co., Ltd.
 Cardiolink Science (Shenzhen) Med Tech Development Co., Ltd. Medical SpecialtiesHealth Technology Cardiolink Science (Shenzhen) Med Tech Development Co., Ltd. develops and sells medical devices for the treatment of dilation of arteriovenous vessels. The company is based in Shenzhen, China. The Chinese company was founded in 2015. The CEO is Peng Sun. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Yi Nan Wang
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Vertrieb & Marketing | - |
Ausbildung von Yi Nan Wang
| Shandong University | Undergraduate Degree |
| Cheung Kong Graduate School of Business | Masters Business Admin |
| East China Normal University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd.
Zhouling Private Equity Fund Management (Shanghai) Co., Ltd. Investment ManagersFinance Zhouling Private Equity Fund Management (Shanghai) Co Ltd (LYFE Capital) is a private equity/venture capital firm founded in 2015 by James Zhao. The firm is headquartered in Shanghai, China. | Finance |
Hangzhou Kangji Medical Instrument Co., Ltd.
Hangzhou Kangji Medical Instrument Co., Ltd. Medical DistributorsDistribution Services Hangzhou Kangji Medical Instrument Co., Ltd. manufactures and distributes medical equipment and related accessories. Its business includes reusable and disposable instruments for laparoscopy, gynecology, urology, gastroenterology, and ENT specialties. The company was founded on August 24, 2004 and is headquartered in Hangzhou, China. | Distribution Services |
Cardiolink Science (Shenzhen) Med Tech Development Co., Ltd.
Cardiolink Science (Shenzhen) Med Tech Development Co., Ltd. Medical SpecialtiesHealth Technology Cardiolink Science (Shenzhen) Med Tech Development Co., Ltd. develops and sells medical devices for the treatment of dilation of arteriovenous vessels. The company is based in Shenzhen, China. The Chinese company was founded in 2015. The CEO is Peng Sun. | Health Technology |
